Jennifer Elisseeff, PhD
Dr. Elisseeff is the Jules Stein Professor at the Wilmer Eye Institute and the Director of the Translational Tissue Engineering Center at Johns Hopkins University. She is a cofounder of Cartilix, Inc, a startup acquired by Biomet, Inc. that translated proven adhesive and biomaterial technologies to the treatment of orthopedic disease. Cartilix was acquired by Biomet, Inc. Dr. Elisseeff is also the founder of Aegeria Soft Tissue and Tissue Repair, companies that are focused on soft tissue regeneration and wound healing. She serves on the Scientific Advisory Boards of Bausch and Lomb and Kythera Biopharmaceutical, and is a fellow of the American Institute for Medical and Biological Engineering and a Young Global Leader of the World Economic Forum. Dr. Elisseeff holds a PhD in biomedical engineering from the Harvard-MIT Division of Health Sciences and Technology and a BS in chemistry from Carnegie Mellon University.
Mr. Post is the former President of the Corneal Refractive Group and Executive Vice President of Advanced Medical Optics (AMO), a global leader in ophthalmic products. At AMO, Mr. Post directed revenues of $1.2 billion with operations in 24 countries and products in 60 countries prior to its acquisition by Abbot. Prior to his position at AMO, Mr. Post was the President and COO of VISX Inc. in Santa Clara, CA, which was listed on the NYSE and was a leader in corneal refractive technology until it was acquired by AMO for $1.3 billion.
Mark Mannis, MD
Professor and chair of the UC Davis Health System Eye Center, Dr. Mannis is widely recognized as a global expert on corneal surgery and disease. In addition to authoring five books and more than 125 articles on these topics, he has served as the Medical Director of the U.C. Davis Medical Center Transplant Bank, the Editor-in-Chief of the peer-reviewed research journal Cornea, the Chairman of the Eye Bank Association of America, the Chairman of the Eye Banking Committee of the American Academy of Ophthalmology, and the 2010 chair of the World Cornea Congress. Dr. Mannis holds a BA from Brandeis University and an MD from the University of Florida College of Medicine.
Dmitri Azar, MD, MBA
An internationally known ophthalmic surgeon, Dr. Azar serves as the Dean of the College of Medicine at the University of Illinois, where he is a professor of Ophthalmology, Bioengineering and Pharmacology. Dr. Azar holds a BS and MD from the American University of Beirut in Lebanon and an executive MBA with High Honors from the University of Chicago Booth School of Business. He served as Chief Resident in Ophthalmology at Harvard Medical School’s Massachusetts Eye and Ear Infimary.
Oliver Schein, MD, MPH
Dr. Schein is the Burton E. Grossman Professor of Ophthalmology at the Wilmer Eye Institute of the Johns Hopkins University School of Medicine, and is jointly appointed to the Department of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health. He has been an author for the American Academy of Ophthalmology’s Preferred Practice Pattern® for cataracts. Dr. Schein received MD and MPH degrees from Johns Hopkins University and served a cornea and external eye disease fellowship and ophthalmology residency at Harvard Medical School’s Massachusetts Eye and Ear Infirmary.